LivaNova PLC (LIVN) Current Ratio
- Current ratio · latest quarter: Value 1.45×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.45× | Current assets / current liabilities. $1.03B ÷ $707.00M ≈ 1.45× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 1.03B USD | Assets, Current |
| Current obligations | 707.00M USD | Liabilities, Current |
| Cash and equivalents | 516.62M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 231.30M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 172.61M USD | Inventory, Net |
| Payables | 103.39M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 175.00K USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.03B | $707.00M | $516.62M | (m) | $231.30M | $172.61M | $103.39M | $175.00K | 1.45× |
| 2026-03-31 | $1.01B | $762.48M | $539.71M | (m) | $229.27M | $165.50M | $99.15M | $121.00K | 1.33× |
| 2025-12-31 | $1.10B | $808.07M | $635.55M | (m) | $215.99M | $164.70M | $97.16M | $30.88M | 1.36× |
| 2025-09-30 | $1.10B | $827.59M | $646.08M | (m) | $211.58M | $167.54M | $88.16M | $85.42M | 1.33× |
| 2025-06-30 | $1.07B | $827.10M | $593.64M | (m) | $220.19M | $165.35M | $86.93M | $82.10M | 1.29× |
| 2025-03-31 | $1.17B | $741.57M | $738.44M | (m) | $202.08M | $154.02M | $87.64M | $78.93M | 1.58× |
| 2024-12-31 | $1.13B | $392.13M | $428.86M | (m) | $193.16M | $147.57M | $69.73M | $77.34M | 2.87× |
| 2024-09-30 | $1.09B | $324.40M | $346.37M | (m) | $197.16M | $162.26M | $77.89M | $21.25M | 3.37× |
| 2024-06-30 | $1.05B | $302.99M | $329.24M | (m) | $200.89M | $154.72M | $81.32M | $19.11M | 3.45× |
| 2024-03-31 | $1.04B | $327.77M | $309.19M | (m) | $209.43M | $153.18M | $75.94M | $19.07M | 3.17× |
| 2023-12-31 | $988.16M | $334.98M | $266.50M | (m) | $215.07M | $147.89M | $80.84M | $17.48M | 2.95× |
| 2023-09-30 | $953.87M | $295.40M | $233.94M | (m) | $189.87M | $161.54M | $62.78M | $18.42M | 3.23× |
| 2023-06-30 | $941.84M | $288.16M | $222.94M | (m) | $185.88M | $156.45M | $78.21M | $18.44M | 3.27× |
| 2023-03-31 | $903.02M | $316.13M | $214.34M | (m) | $178.32M | $142.45M | $75.73M | $21.56M | 2.86× |
| 2022-12-31 | $886.14M | $297.40M | $214.17M | (m) | $183.11M | $129.38M | $74.31M | $20.89M | 2.98× |
| 2022-09-30 | $851.22M | $288.02M | $231.11M | (m) | $172.09M | $122.04M | $69.62M | $18.75M | 2.96× |
| 2022-06-30 | $771.93M | $263.89M | $109.02M | (m) | $176.95M | $119.42M | $74.35M | $3.21M | 2.93× |
| 2022-03-31 | $809.62M | $307.91M | $128.74M | (m) | $182.11M | $114.84M | $73.92M | $1.73M | 2.63× |
| 2021-12-31 | $679.18M | $696.97M | $207.99M | (m) | $185.35M | $105.84M | $68.00M | $226.95M | 0.97× |
| 2021-09-30 | $646.36M | $658.47M | $181.85M | (m) | $182.01M | $123.73M | $60.25M | $223.61M | 0.98× |
| 2021-06-30 | $809.10M | $702.25M | $329.39M | (m) | $182.18M | $127.17M | $61.33M | $226.98M | 1.15× |
| 2021-03-31 | $690.63M | $295.36M | $252.54M | (m) | $180.71M | $124.52M | $62.45M | $7.70M | 2.34× |
| 2020-12-31 | $708.04M | $309.05M | $252.83M | (m) | $184.36M | $115.28M | $73.67M | $8.38M | 2.29× |
| 2020-09-30 | $673.14M | $281.76M | $227.81M | (m) | $191.89M | $178.09M | $71.60M | $9.69M | 2.39× |
| 2020-06-30 | $672.44M | $268.36M | $232.55M | (m) | $186.14M | $177.25M | $69.06M | $3.64M | 2.51× |
| 2020-03-31 | $616.92M | $529.72M | (m) | (m) | $225.35M | $170.26M | $91.22M | $176.14M | 1.16× |
| 2019-12-31 | $549.44M | $512.55M | $61.14M | (m) | $257.77M | $164.15M | $85.89M | $73.18M | 1.07× |
| 2019-09-30 | $546.85M | $469.19M | $75.31M | (m) | $243.18M | $167.76M | $75.52M | $65.68M | 1.17× |
| 2019-06-30 | $568.44M | $595.91M | $44.51M | (m) | $256.12M | $168.67M | $88.52M | $29.81M | 0.95× |
| 2019-03-31 | $540.60M | $622.31M | $50.78M | (m) | $247.06M | $161.27M | $80.20M | $22.88M | 0.87× |
| 2018-12-31 | $533.30M | $496.75M | $47.20M | (m) | $256.13M | $153.53M | $76.73M | $23.30M | 1.07× |
| 2018-09-30 | $573.24M | $347.07M | $79.95M | (m) | $252.30M | $153.06M | $88.88M | $23.58M | 1.65× |
| 2018-06-30 | $554.69M | $368.02M | $47.38M | (m) | $261.92M | $157.83M | $86.91M | $21.64M | 1.51× |
| 2018-03-31 | $848.07M | $459.48M | $64.96M | (m) | $279.83M | $154.33M | $89.92M | $25.07M | 1.85× |
| 2017-12-31 | $869.86M | $406.02M | $93.61M | (m) | $282.14M | $144.47M | $85.92M | $25.84M | 2.14× |
| 2017-09-30 | $722.05M | $356.36M | $65.16M | (m) | $314.04M | $214.59M | $102.65M | $24.12M | 2.03× |
| 2017-06-30 | $671.38M | $342.45M | $42.69M | (m) | $305.36M | $204.68M | $105.11M | $23.35M | 1.96× |
| 2017-03-31 | $660.68M | $323.83M | $62.72M | (m) | $271.53M | $192.39M | $101.95M | $21.59M | 2.04× |
| 2016-12-31 | $812.69M | $349.89M | $39.79M | (m) | $213.26M | $133.02M | $71.93M | $21.30M | 2.32× |
| 2016-09-30 | $647.33M | $316.89M | $63.63M | (m) | $284.35M | $197.65M | $104.55M | $22.03M | 2.04× |
| 2016-06-30 | $662.34M | $343.91M | $63.89M | (m) | $299.63M | $192.73M | $121.15M | $21.35M | 1.93× |
| 2016-03-31 | $683.67M | $381.55M | $87.47M | (m) | $288.54M | $210.76M | $118.86M | $21.95M | 1.79× |
| 2015-12-31 | $673.41M | $359.12M | $112.61M | (m) | $272.35M | $212.45M | $109.59M | $21.24M | 1.88× |
| 2015-10-18 | $282.41M | $71.01M | $189.78M | (m) | $45.57M | $25.94M | $15.61M | (m) | 3.98× |
| 2015-04-24 | $240.72M | $31.45M | $124.19M | (m) | $50.57M | $23.96M | $7.25M | (m) | 7.65× |
| 2014-04-25 | $220.43M | $29.90M | $103.30M | (m) | $50.67M | $17.63M | $7.57M | (m) | 7.37× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |